[go: up one dir, main page]

ES506018A0 - Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios - Google Patents

Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios

Info

Publication number
ES506018A0
ES506018A0 ES506018A ES506018A ES506018A0 ES 506018 A0 ES506018 A0 ES 506018A0 ES 506018 A ES506018 A ES 506018A ES 506018 A ES506018 A ES 506018A ES 506018 A0 ES506018 A0 ES 506018A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
pharmaceutical composition
based pharmaceutical
inflammatory steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506018A
Other languages
English (en)
Other versions
ES8306591A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8306591A1 publication Critical patent/ES8306591A1/es
Publication of ES506018A0 publication Critical patent/ES506018A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES506018A 1980-10-06 1981-10-05 Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios Granted ES506018A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8032111 1980-10-06

Publications (2)

Publication Number Publication Date
ES8306591A1 ES8306591A1 (es) 1983-06-01
ES506018A0 true ES506018A0 (es) 1983-06-01

Family

ID=10516496

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506018A Granted ES506018A0 (es) 1980-10-06 1981-10-05 Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios

Country Status (18)

Country Link
US (1) US4370322A (es)
JP (1) JPS5793907A (es)
AU (1) AU7602781A (es)
BE (1) BE890633A (es)
CA (1) CA1182048A (es)
CH (1) CH649923A5 (es)
DE (1) DE3139519A1 (es)
DK (1) DK440081A (es)
ES (1) ES506018A0 (es)
FI (1) FI821167A7 (es)
FR (1) FR2491333B1 (es)
IT (1) IT1171569B (es)
NL (1) NL8104512A (es)
NO (1) NO820982L (es)
NZ (1) NZ198553A (es)
PT (1) PT73772B (es)
SE (1) SE8105867L (es)
ZA (1) ZA816872B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4515810A (en) * 1983-10-06 1985-05-07 American Cyanamid Company Composition of matter
JPS615009A (ja) * 1984-05-31 1986-01-10 Mochida Pharmaceut Co Ltd 制癌用磁性小胞体組成物
JPS62138432A (ja) * 1985-12-12 1987-06-22 Shionogi & Co Ltd 抗炎症ステロイドを含有する安定な錠剤
US5326566A (en) * 1991-05-17 1994-07-05 Bristol-Myers Squibb Company Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
CA2452152A1 (en) * 2001-07-02 2002-10-10 Sinan Tas Use of cyclopamine in the treatment of psoriasis
KR20040034795A (ko) * 2002-10-17 2004-04-29 박래옥 스테로이드 제제 및 태반 추출물을 함유한 염증성 피부병치료용 경피제
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
DK2704687T3 (en) * 2011-05-04 2015-10-05 Chiesi Farma Spa Topical formulation having a corticosteroid as an active ingredient
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792455A1 (de) * 1968-09-05 1971-11-11 Baerlocher Chem Verwendung von Estern natuerlicher Fettsaeuregemische in kosmetischen und pharmazeutischen Zubereitungen sowie Reinigungsmitteln und Toilettenseifen
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
NL7800762A (nl) * 1978-01-20 1979-07-24 Acf Chemiefarma Nv Vloeibare, voor injectie geschikte farmaceu- tische samenstellingen.
US4233295A (en) * 1979-05-31 1980-11-11 E. R. Squibb & Sons, Inc. Corticosteroid formulations containing sebacate carrier

Also Published As

Publication number Publication date
AU7602781A (en) 1982-04-22
DK440081A (da) 1982-04-07
FI821167A0 (fi) 1982-04-02
NO820982L (no) 1983-09-26
DE3139519A1 (de) 1982-06-16
PT73772B (en) 1983-10-14
NL8104512A (nl) 1982-05-03
US4370322A (en) 1983-01-25
FI821167L (fi) 1983-10-03
FR2491333B1 (fr) 1985-09-27
IT8149422A0 (it) 1981-10-05
IT1171569B (it) 1987-06-10
IT8149422A1 (it) 1983-04-05
CH649923A5 (de) 1985-06-28
FR2491333A1 (fr) 1982-04-09
SE8105867L (sv) 1982-04-07
CA1182048A (en) 1985-02-05
JPS5793907A (en) 1982-06-11
ZA816872B (en) 1982-09-29
ES8306591A1 (es) 1983-06-01
PT73772A (en) 1981-11-01
NZ198553A (en) 1983-09-30
BE890633A (fr) 1982-04-05
FI821167A7 (fi) 1983-10-03

Similar Documents

Publication Publication Date Title
ES498055A0 (es) Un procedimiento para la preparacion de una piridilanilina
ES526868A0 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES524892A0 (es) Un procedimiento para la preparacion de una tableta farmaceutica
ES486157A0 (es) Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES493986A0 (es) Un procedimiento para la preparacion de una mezcla hidrocar-burada
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES506018A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES535980A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina
ES499609A0 (es) Un procedimiento para la preparacion de una 3-yodometil-ce- falosporina
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES500897A0 (es) Un procedimiento para la preparacion de una mezcla de hidro-carburos
ES530669A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES503682A0 (es) Un procedimiento para la preparacion de una isoxazolilimida-zolidinona
ES492230A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
ES490453A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
MX7581E (es) Procedimiento para preparar una composicion farmaceutica a base de famotidina
AR230570A1 (es) Procedimiento para la preparacion de nuevas composiciones farmaceuticas antiulcerosas
ES485554A0 (es) Un procedimiento para la preparacion de derivados de 5-fluoruracilo
ES540344A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica